• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合分析确定了一类雄激素反应基因,这些基因受 CTCF 介导的短组合长程机制调控。

Integrated analysis identifies a class of androgen-responsive genes regulated by short combinatorial long-range mechanism facilitated by CTCF.

机构信息

Department of Statistics, The Ohio State University, Columbus, OH 43210, USA.

出版信息

Nucleic Acids Res. 2012 Jun;40(11):4754-64. doi: 10.1093/nar/gks139. Epub 2012 Feb 16.

DOI:10.1093/nar/gks139
PMID:22344698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3367180/
Abstract

Recently, much attention has been given to elucidate how long-range gene regulation comes into play and how histone modifications and distal transcription factor binding contribute toward this mechanism. Androgen receptor (AR), a key regulator of prostate cancer, has been shown to regulate its target genes via distal enhancers, leading to the hypothesis of global long-range gene regulation. However, despite numerous flows of newly generated data, the precise mechanism with respect to AR-mediated long-range gene regulation is still largely unknown. In this study, we carried out an integrated analysis combining several types of high-throughput data, including genome-wide distribution data of H3K4 di-methylation (H3K4me2), CCCTC binding factor (CTCF), AR and FoxA1 cistrome data as well as androgen-regulated gene expression data. We found that a subset of androgen-responsive genes was significantly enriched near AR/H3K4me2 overlapping regions and FoxA1 binding sites within the same CTCF block. Importantly, genes in this class were enriched in cancer-related pathways and were downregulated in clinical metastatic versus localized prostate cancer. Our results suggest a relatively short combinatorial long-range regulation mechanism facilitated by CTCF blocking. Under such a mechanism, H3K4me2, AR and FoxA1 within the same CTCF block combinatorially regulate a subset of distally located androgen-responsive genes involved in prostate carcinogenesis.

摘要

最近,人们越来越关注阐明远程基因调控是如何发挥作用的,以及组蛋白修饰和远端转录因子结合如何有助于这一机制。雄激素受体(AR)是前列腺癌的关键调节因子,已经被证明通过远端增强子来调节其靶基因,从而产生了全局远程基因调控的假设。然而,尽管有大量新生成的数据,但 AR 介导的远程基因调控的确切机制在很大程度上仍然未知。在这项研究中,我们进行了一项综合分析,结合了几种类型的高通量数据,包括 H3K4 二甲基化(H3K4me2)、CCCTC 结合因子(CTCF)、AR 和 FoxA1 顺式作用元件数据以及雄激素调节基因表达数据。我们发现,一组雄激素反应基因在 AR/H3K4me2 重叠区域和同一 CTCF 块内的 FoxA1 结合位点附近显著富集。重要的是,这类基因富集在与癌症相关的途径中,并且在临床转移性与局部前列腺癌中下调。我们的结果表明,一种相对较短的组合远程调控机制是由 CTCF 阻断介导的。在这种机制下,同一 CTCF 块内的 H3K4me2、AR 和 FoxA1 组合调控一组远端雄激素反应基因,这些基因参与前列腺癌的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/d2f82ff5e141/gks139f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/3292d7047be9/gks139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/cd73f2e03ec4/gks139f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/a3d928cfe4d1/gks139f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/24d105f7190e/gks139f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/9233c178f571/gks139f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/d2f82ff5e141/gks139f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/3292d7047be9/gks139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/cd73f2e03ec4/gks139f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/a3d928cfe4d1/gks139f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/24d105f7190e/gks139f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/9233c178f571/gks139f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c2e/3367180/d2f82ff5e141/gks139f6.jpg

相似文献

1
Integrated analysis identifies a class of androgen-responsive genes regulated by short combinatorial long-range mechanism facilitated by CTCF.整合分析确定了一类雄激素反应基因,这些基因受 CTCF 介导的短组合长程机制调控。
Nucleic Acids Res. 2012 Jun;40(11):4754-64. doi: 10.1093/nar/gks139. Epub 2012 Feb 16.
2
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.达罗他胺通过阻断增强子和超级增强子的激活来拮抗雄激素信号。
Mol Oncol. 2020 Sep;14(9):2022-2039. doi: 10.1002/1878-0261.12693. Epub 2020 Jun 5.
3
Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.先驱因子GATA2在促进前列腺癌雄激素依赖性基因表达中的三重作用。
Nucleic Acids Res. 2014 Apr;42(6):3607-22. doi: 10.1093/nar/gkt1382. Epub 2014 Jan 13.
4
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.雄激素受体在雄激素非依赖性前列腺癌中调控着一个独特的转录程序。
Cell. 2009 Jul 23;138(2):245-56. doi: 10.1016/j.cell.2009.04.056.
5
SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.小泛素样修饰蛋白连接酶PIAS1在前列腺癌细胞染色质上作为靶基因选择性雄激素受体共调节因子发挥作用。
Nucleic Acids Res. 2015 Jan;43(2):848-61. doi: 10.1093/nar/gku1375. Epub 2014 Dec 30.
6
Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.整合基因表达的帽分析和染色质免疫沉淀分析阵列揭示了前列腺癌细胞中的全基因组雄激素受体信号。
Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4.
7
Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.Foxa1和Foxa2与雄激素受体相互作用,以差异调节前列腺和附睾基因。
Ann N Y Acad Sci. 2005 Dec;1061:77-93. doi: 10.1196/annals.1336.009.
8
Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.与FOXA1的协同作用和平衡决定了雄激素受体转录程序。
Nat Commun. 2014 May 30;5:3972. doi: 10.1038/ncomms4972.
9
Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.FoxA1 在前列腺癌转移中的雄激素受体非依赖性功能。
Cancer Res. 2013 Jun 15;73(12):3725-36. doi: 10.1158/0008-5472.CAN-12-3468. Epub 2013 Mar 28.
10
Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer.CTCF 和 FOXA1 与局限性前列腺癌男性雄激素和 IGF 通路的相关性。
Growth Horm IGF Res. 2023 Apr-Jun;69-70:101533. doi: 10.1016/j.ghir.2023.101533. Epub 2023 Apr 14.

引用本文的文献

1
Transcription factors and hormone receptors: Sex‑specific targets for cancer therapy (Review).转录因子与激素受体:癌症治疗的性别特异性靶点(综述)
Oncol Lett. 2024 Dec 6;29(2):93. doi: 10.3892/ol.2024.14839. eCollection 2025 Feb.
2
Systematic Multi-Omics Investigation of Androgen Receptor Driven Gene Expression and Epigenetics changes in Prostate Cancer.雄激素受体驱动的前列腺癌基因表达和表观遗传学变化的系统多组学研究
bioRxiv. 2024 Jul 23:2024.07.22.604505. doi: 10.1101/2024.07.22.604505.
3
An in silico procedure for generating protein-mediated chromatin interaction data and comparison of significant interaction calling methods.

本文引用的文献

1
FOXA1: master of steroid receptor function in cancer.FOXA1:癌症中甾体激素受体功能的主宰者。
EMBO J. 2011 Sep 20;30(19):3885-94. doi: 10.1038/emboj.2011.340.
2
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.FoxA1 在雄激素受体与染色质结合、雄激素信号传导和前列腺癌中的双重作用。
EMBO J. 2011 Sep 13;30(19):3962-76. doi: 10.1038/emboj.2011.328.
3
Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer.定义 FoxA1 顺式作用元件,对于去势抵抗性前列腺癌中 G1 期到 S 期细胞周期转换至关重要。
一种生成蛋白质介导的染色质相互作用数据的计算程序以及比较显著相互作用调用方法。
PLoS One. 2024 Jan 17;19(1):e0287521. doi: 10.1371/journal.pone.0287521. eCollection 2024.
4
Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.前列腺癌表观遗传可塑性和增强子异质性:分子原因、后果和临床意义。
Adv Exp Med Biol. 2022;1390:255-275. doi: 10.1007/978-3-031-11836-4_15.
5
Androgen receptor signaling and spatial chromatin organization in castration-resistant prostate cancer.去势抵抗性前列腺癌中的雄激素受体信号传导与空间染色质组织
Front Med (Lausanne). 2022 Jul 29;9:924087. doi: 10.3389/fmed.2022.924087. eCollection 2022.
6
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.前列腺癌发生、进展及治疗反应中的染色质与表观遗传失调
Cancers (Basel). 2021 Jul 2;13(13):3325. doi: 10.3390/cancers13133325.
7
BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression.BRD9是雄激素受体信号传导和前列腺癌进展的关键调节因子。
Cancer Res. 2021 Feb 15;81(4):820-833. doi: 10.1158/0008-5472.CAN-20-1417. Epub 2020 Dec 21.
8
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.达罗他胺通过阻断增强子和超级增强子的激活来拮抗雄激素信号。
Mol Oncol. 2020 Sep;14(9):2022-2039. doi: 10.1002/1878-0261.12693. Epub 2020 Jun 5.
9
Exploring the changing landscape of cell-to-cell variation after CTCF knockdown via single cell RNA-seq.通过单细胞 RNA-seq 探索 CTCF 敲低后细胞间变异性的变化格局。
BMC Genomics. 2019 Dec 26;20(1):1015. doi: 10.1186/s12864-019-6379-5.
10
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer.CCCTC 结合因子(CTCF)的表达与前列腺癌的预后不良有关。
Mol Oncol. 2020 Jan;14(1):129-138. doi: 10.1002/1878-0261.12597. Epub 2019 Nov 29.
Cancer Res. 2011 Nov 1;71(21):6738-6748. doi: 10.1158/0008-5472.CAN-11-1882. Epub 2011 Sep 7.
4
Androgen receptor-driven chromatin looping in prostate cancer.雄激素受体驱动的前列腺癌染色质环化。
Trends Endocrinol Metab. 2011 Dec;22(12):474-80. doi: 10.1016/j.tem.2011.07.006. Epub 2011 Aug 31.
5
CTCF-mediated functional chromatin interactome in pluripotent cells.CTCF 介导的多能细胞功能染色质互作组
Nat Genet. 2011 Jun 19;43(7):630-8. doi: 10.1038/ng.857.
6
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.通过功能定义的不同类别增强子重编程转录,这些增强子由 eRNA 定义。
Nature. 2011 May 15;474(7351):390-4. doi: 10.1038/nature10006.
7
Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.磷酸化-MED1 增强的 UBE2C 基因座环化驱动去势抵抗性前列腺癌生长。
EMBO J. 2011 May 10;30(12):2405-19. doi: 10.1038/emboj.2011.154.
8
Functional and mechanistic diversity of distal transcription enhancers.远端转录增强子的功能和机制多样性。
Cell. 2011 Feb 4;144(3):327-39. doi: 10.1016/j.cell.2011.01.024.
9
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.涉及启动因子 FOXA1 依赖性增强子激活的表观遗传开关。
Genome Res. 2011 Apr;21(4):555-65. doi: 10.1101/gr.111534.110. Epub 2011 Jan 13.
10
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.雄激素受体、多梳、TMPRSS2-ERG 基因融合在前列腺癌进展中的整合网络。
Cancer Cell. 2010 May 18;17(5):443-54. doi: 10.1016/j.ccr.2010.03.018.